Bristol-Myers Squibb Co at Jefferies London Healthcare Conference Transcript
Last day, exciting stuff. London Healthcare Conference. My name is Akash Tewari. Can you even pronounce my name? I'm a pharma and biotech analyst here at Jefferies. I have the pleasure of hosting Tim Power, Head of Bristol IR, for a nice one-on-one fireside chat discussion today. Tim, let me hand it to you for some opening remarks, and then we'll get started.
Thanks very much, Akash, and thanks for the opportunity to be here this morning. I mean I suppose if I just take a step back, where we are right now. Clearly, the company is going through an important patent cycle at the moment, and the market is obviously focused on that understandably. I think that if we sort of put that in context, thinking about the fact that this isn't the first time Bristol has gone through a patent cycle.
And frankly, we've seen some other companies more recently go through something similar and come out very strong on the other side, I think it
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |